SlideShare a Scribd company logo
1 of 4
Aarkstore.com announces, The Latest market research report is available in
its vast collection:

GPCR - DRUG TARGETS


http://www.aarkstore.com/reports/GPCR-DRUG-TARGETS-134288.html


You can also request for sample page of above mention reports on
sample@aarkstore.com



This market insight report on G-Protein Coupled Receptors (GPCR) covers the types
of GPCR Families and the various ligands targeting GPCR. The GPCR families covered
include Rhodopsin, Secretin, Metabotropic glutamate and Other. The Ligands
targeting GPCRs include Peptides or Proteins, Biogenic Amines, Lipids and Other.
The report provides market analysis of each of the Families and ligands targeting
GPCRs by their respective categories. The study includes estimations and
predictions for the total global GPCR – Drug targets market and also key regional
markets that include North America, Europe, Japan, Asia-Pacific (excluding Japan)
and Rest of World. Estimations and predictions (2005-2015) are illustrated
graphically with 60 exhibits. Business profiles of 13 major companies engaged in
developing GPCR targeted drugs, GPCR cell lines and GPCR Assays are discussed in
the report. The report serves as a guide to global GPCR –Drug Targets industry,
covering more than 100 companies that are engaged in the development of GPCR
Targeted Drugs, GPCR Assays Information related to recent product releases, Assay
developments, partnerships, collaborations, and mergers and acquisitions is also
covered in the report. Compilation of Worldwide Patents and Research related to
GPCR Drug Targets is also provided.


Table of contents:

I. SCOPE AND METHODOLOGY
II. REPORT SYNOPSIS
1. Introduction
Agonist
Antagonist
GEFs (Guanine Nucleotide Exchange Factor)
Receptor Regulation
Receptor Desensitization
Ras SuperFamily
GPCR
Products of GPCR and Profiling Services
GPCRs as Drug Targets
Cell Surface Receptor Expression of a High Order
Functionally Oriented GPCR
The Purpose of GPCR Profiling
The Speeding Up of Successful Drug Discovery
Secondary and Custom Assay Services
Advantages
History of GPCR
Other Receptors
G-Protein
History of G-Proteins
Segmentation of GPCR – Drug Targets
Exhibit 1: Segmentation of Global GPCR –Drug Targets Market by GPCR Families
(Rhodopsin, Secretin,
Glutamate and Other) and by type of Ligands Targeting GPCRs (Peptides or Proteins
including enzymes, Biogenic Amines, Lipids and Other)
2. Global Market Analysis
Exhibit 2: GPCR – Drug Targets - Global Value Market Estimations & Predictions
(2005 -2015) in US$ Billion (Graphical Representation Included)
Analysis by GPCR Family Type
Rhodopsin
Exhibit 3: Rhodopsin - Global Value Market Estimations & Predictions (2005 -2015)
by Geographic Region for United States, Europe, Japan, Asia-Pacific and Rest of
World in US$ Billion (Graphical Representation Included)

For more Reports Plz follow The link:

STEM CELL RESEARCH IN CARDIOLOGY
UNNATURAL AMINO ACIDS

VETERINARY VACCINES

GPCR - DRUG TARGETS

STEM CELL RESEARCH

Biosensors

Biodegradable Stents

Branched Chain Amino Acids

FEED NUCLEOTIDES

BIOMARKERS

METABOLOMICS



Search More Reports Related to This Category :

http://www.aarkstore.com/publishers/pubreports.asp?PubId=35&pagenum=1



GPCR
http://www.aarkstore.com/search/viewresults.asp?search=GPCR&PubId=&pagen
um=1




For More details Plz do contact :
Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

More Related Content

More from Rose088

Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
Rose088
 

More from Rose088 (20)

Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 

Recently uploaded

Structuring Teams and Portfolios for Success
Structuring Teams and Portfolios for SuccessStructuring Teams and Portfolios for Success
Structuring Teams and Portfolios for Success
UXDXConf
 

Recently uploaded (20)

Using IESVE for Room Loads Analysis - UK & Ireland
Using IESVE for Room Loads Analysis - UK & IrelandUsing IESVE for Room Loads Analysis - UK & Ireland
Using IESVE for Room Loads Analysis - UK & Ireland
 
Easier, Faster, and More Powerful – Notes Document Properties Reimagined
Easier, Faster, and More Powerful – Notes Document Properties ReimaginedEasier, Faster, and More Powerful – Notes Document Properties Reimagined
Easier, Faster, and More Powerful – Notes Document Properties Reimagined
 
The Metaverse: Are We There Yet?
The  Metaverse:    Are   We  There  Yet?The  Metaverse:    Are   We  There  Yet?
The Metaverse: Are We There Yet?
 
WebRTC and SIP not just audio and video @ OpenSIPS 2024
WebRTC and SIP not just audio and video @ OpenSIPS 2024WebRTC and SIP not just audio and video @ OpenSIPS 2024
WebRTC and SIP not just audio and video @ OpenSIPS 2024
 
Intro in Product Management - Коротко про професію продакт менеджера
Intro in Product Management - Коротко про професію продакт менеджераIntro in Product Management - Коротко про професію продакт менеджера
Intro in Product Management - Коротко про професію продакт менеджера
 
TopCryptoSupers 12thReport OrionX May2024
TopCryptoSupers 12thReport OrionX May2024TopCryptoSupers 12thReport OrionX May2024
TopCryptoSupers 12thReport OrionX May2024
 
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
ASRock Industrial FDO Solutions in Action for Industrial Edge AI _ Kenny at A...
 
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdfLinux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
 
How we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdfHow we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdf
 
The Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdf
The Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdfThe Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdf
The Value of Certifying Products for FDO _ Paul at FIDO Alliance.pdf
 
Designing for Hardware Accessibility at Comcast
Designing for Hardware Accessibility at ComcastDesigning for Hardware Accessibility at Comcast
Designing for Hardware Accessibility at Comcast
 
PLAI - Acceleration Program for Generative A.I. Startups
PLAI - Acceleration Program for Generative A.I. StartupsPLAI - Acceleration Program for Generative A.I. Startups
PLAI - Acceleration Program for Generative A.I. Startups
 
TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...
TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...
TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...
 
WebAssembly is Key to Better LLM Performance
WebAssembly is Key to Better LLM PerformanceWebAssembly is Key to Better LLM Performance
WebAssembly is Key to Better LLM Performance
 
Enterprise Knowledge Graphs - Data Summit 2024
Enterprise Knowledge Graphs - Data Summit 2024Enterprise Knowledge Graphs - Data Summit 2024
Enterprise Knowledge Graphs - Data Summit 2024
 
What's New in Teams Calling, Meetings and Devices April 2024
What's New in Teams Calling, Meetings and Devices April 2024What's New in Teams Calling, Meetings and Devices April 2024
What's New in Teams Calling, Meetings and Devices April 2024
 
Long journey of Ruby Standard library at RubyKaigi 2024
Long journey of Ruby Standard library at RubyKaigi 2024Long journey of Ruby Standard library at RubyKaigi 2024
Long journey of Ruby Standard library at RubyKaigi 2024
 
A Business-Centric Approach to Design System Strategy
A Business-Centric Approach to Design System StrategyA Business-Centric Approach to Design System Strategy
A Business-Centric Approach to Design System Strategy
 
Continuing Bonds Through AI: A Hermeneutic Reflection on Thanabots
Continuing Bonds Through AI: A Hermeneutic Reflection on ThanabotsContinuing Bonds Through AI: A Hermeneutic Reflection on Thanabots
Continuing Bonds Through AI: A Hermeneutic Reflection on Thanabots
 
Structuring Teams and Portfolios for Success
Structuring Teams and Portfolios for SuccessStructuring Teams and Portfolios for Success
Structuring Teams and Portfolios for Success
 

Gpcr drug targets

  • 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: GPCR - DRUG TARGETS http://www.aarkstore.com/reports/GPCR-DRUG-TARGETS-134288.html You can also request for sample page of above mention reports on sample@aarkstore.com This market insight report on G-Protein Coupled Receptors (GPCR) covers the types of GPCR Families and the various ligands targeting GPCR. The GPCR families covered include Rhodopsin, Secretin, Metabotropic glutamate and Other. The Ligands targeting GPCRs include Peptides or Proteins, Biogenic Amines, Lipids and Other. The report provides market analysis of each of the Families and ligands targeting GPCRs by their respective categories. The study includes estimations and predictions for the total global GPCR – Drug targets market and also key regional markets that include North America, Europe, Japan, Asia-Pacific (excluding Japan) and Rest of World. Estimations and predictions (2005-2015) are illustrated graphically with 60 exhibits. Business profiles of 13 major companies engaged in developing GPCR targeted drugs, GPCR cell lines and GPCR Assays are discussed in the report. The report serves as a guide to global GPCR –Drug Targets industry, covering more than 100 companies that are engaged in the development of GPCR Targeted Drugs, GPCR Assays Information related to recent product releases, Assay developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Compilation of Worldwide Patents and Research related to GPCR Drug Targets is also provided. Table of contents: I. SCOPE AND METHODOLOGY II. REPORT SYNOPSIS 1. Introduction Agonist
  • 2. Antagonist GEFs (Guanine Nucleotide Exchange Factor) Receptor Regulation Receptor Desensitization Ras SuperFamily GPCR Products of GPCR and Profiling Services GPCRs as Drug Targets Cell Surface Receptor Expression of a High Order Functionally Oriented GPCR The Purpose of GPCR Profiling The Speeding Up of Successful Drug Discovery Secondary and Custom Assay Services Advantages History of GPCR Other Receptors G-Protein History of G-Proteins Segmentation of GPCR – Drug Targets Exhibit 1: Segmentation of Global GPCR –Drug Targets Market by GPCR Families (Rhodopsin, Secretin, Glutamate and Other) and by type of Ligands Targeting GPCRs (Peptides or Proteins including enzymes, Biogenic Amines, Lipids and Other) 2. Global Market Analysis Exhibit 2: GPCR – Drug Targets - Global Value Market Estimations & Predictions (2005 -2015) in US$ Billion (Graphical Representation Included) Analysis by GPCR Family Type Rhodopsin Exhibit 3: Rhodopsin - Global Value Market Estimations & Predictions (2005 -2015) by Geographic Region for United States, Europe, Japan, Asia-Pacific and Rest of World in US$ Billion (Graphical Representation Included) For more Reports Plz follow The link: STEM CELL RESEARCH IN CARDIOLOGY
  • 3. UNNATURAL AMINO ACIDS VETERINARY VACCINES GPCR - DRUG TARGETS STEM CELL RESEARCH Biosensors Biodegradable Stents Branched Chain Amino Acids FEED NUCLEOTIDES BIOMARKERS METABOLOMICS Search More Reports Related to This Category : http://www.aarkstore.com/publishers/pubreports.asp?PubId=35&pagenum=1 GPCR http://www.aarkstore.com/search/viewresults.asp?search=GPCR&PubId=&pagen um=1 For More details Plz do contact :